Health Biotechnology and Biopharma
Health Biotechnology and Biopharma (HBB, ISSN: 2538-4414) is a quarterly peer-reviewed journal which promotes latest research which emphasizes on all areas of health biotechnology and biopharma. It is an open access, peer-reviewed and online scientific journal. The aim of this journal is to provide a platform for researchers to promote innovative research. This journal consists of the following sections:
• BioPharm Hypothesis
• Original Research/ Review Article
• Short Communication/ Opinion/ Letter
In the field of pharmaceutical, biological, medicinal and chemical sciences. Bio/Pharm Hypothesis provides novel and innovative ideas in biopharmaceutics, opening the field to radical hypothesis based on non-experimental and experimental research. We assign all articles to Digital Object Identifier (DOI ) of mEDRA. Please submit your manuscript online.
Publisher:
Health Biotechnology and Biopharma
Editor-in-Chief:
Dr. Soroush Sardari
Executive Manager:
Dr. Masoomeh Shirzad
Frequency: Quarterly
Online ISSN: 2538-4414
Pages 1-12
Pages 13-25
Pages 26-32
Pages 33-52
Pages 53-61
Pages 62-81
Volume 5, Issue 2, September 2021, Pages 1-6
Volume 5, Issue 2, September 2021, Pages 46-60
Volume 6, Issue 1, June 2022, Pages 62-81
Volume 5, Issue 4, March 2022, Pages 55-85
Volume 5, Issue 2, September 2021, Pages 26-33
Articles in Press, Accepted Manuscript, Available Online from 27 June 2022
', './data/hbb/coversheet/cover_en.jpg'))